Roussel, M., Kastritis, E., Schönland, S., Kortüm, K. M., Arnulf, B., Jaccard, A., Vara, S., Doyle, M., Schecter, J., Carpinteiro, A., Kwok, F., Palladini, G., Minnema, M., Boccadoro, M., Sonneveld, P. (2025). TeclistAMY (EMN40): A Phase 2 trial of teclistamab in patients with previously treated light-chain (AL) amyloidosis. Blood. https://doi.org/10.1182/blood-2025-3974